English ▼
Arabic
Chinese
German
French
Spanish
Portuguese
Vietnamese
Korean
Urdu (Pakistan)
Tagalog (Phillipines)
Hausa (Nigeria)Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent (OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
Top 10 Federal Compliance Risks for Hospitals
Hospitals in the United States face numerous compliance risks. Multiple federal agencies oversee hospitals’ compliance efforts, and directors, administrators, and compliance officers must thoroughly assess their facilities’ compliance efforts on an ongoing basis to ensure that this oversight does not lead to recoupments, loss of program eligibility, or other penalties....
Read more
What to Do When Facing a Federal Investigation for COVID Health Care Fraud
The U.S. Department of Justice (DOJ) and multiple other federal agencies are aggressively targeting health care providers and other businesses suspected of taking advantage of the COVID-19 pandemic to defraud patients, consumers, businesses and government entities. These agencies are targeting a wide range of offenses, and federal prosecutors are seeking...
Read more
The DOJ is Continuing to Target Multiple Forms of Fraud Related to COVID-19 in 2021
As the federal government races to get as many people vaccinated against COVID-19 as possible, the U.S. Department of Justice (DOJ) is waging a war on a different front. The DOJ has identified several forms of fraud arising out of the pandemic, and it is continuing to aggressively target individuals...
Read more
Foreign Bank Accounts, Cryptocurrency & the IRS: What U.S. Taxpayers Need to Know
The Internal Revenue Service (IRS) is cracking down on U.S. taxpayers who own foreign bank accounts and cryptocurrency in 2021. Both of these have been priority enforcement areas for the IRS in recent years, and the IRS has made clear that it intends to continue auditing and investigating taxpayers who...
Read more
OIG Compliance Guidance for Pharmaceutical Manufacturers
The OIG's long-standing guidance for pharmaceutical manufacturers provides a roadmap for compliance. The OIG expects pharmaceutical manufacturers to adapt this guidance to their specific operations, and to implement compliance programs that effectively mitigate the risk of fraud and abuse. Pharmaceutical manufacturers in the U.S. face a host of federal compliance...
Read more
Tips and Strategies for Defending Against a DOL Audit
The U.S. Department of Labor (DOL) is the federal agency responsible for enforcing the nation's employment laws. It has broad authority over companies' employment practices, with its jurisdiction covering everything from wages to workplace safety, and from employment discrimination to federal benefit programs. Given the breadth of the DOL's authority,...
Read more
OIG Compliance Program Guidance for Clinical Laboratories
Clinical laboratories have substantial compliance obligations. In addition to general corporate compliance matters and compliance with the laws and regulations enforced by the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA), this includes compliance with the standards established by the U.S. Department of Health and Human...
Read more
OIG Compliance Program Guidance for Physician Practices
Whether you are preparing to open your own practice or you have questions or concerns about your existing practice's compliance efforts, you need to make informed decisions when it comes to evaluating your practice's compliance needs. While there are numerous aspects to compliance for physician practices, one of the more-important...
Read more
CBD: Compliance, Risk Management, and Investigation Defense
Pharmacies and businesses that manufacture, distribute, and sell CBD products are subject to numerous laws and regulations. Our lawyers and former federal agents assist with all aspects of compliance, risk management, and defense. It is no secret that CBD is now big business in the United States. With more states...
Read more
Facing Discipline Under SEC Rule 102(e): What Professionals Need to Know
While the U.S. Securities and Exchange Commission (SEC) has substantial resources at its disposal, it cannot fully monitor the domestic securities markets and enforce companies’ obligations under the Securities Act of 1933 and the Securities Exchange Act of 1934 on its own. As a result, it relies on so-called “gatekeepers”—attorneys,...
Read more
